On this page

Study design

Researchers combined mouse stroke experiments with analyses of human ischemic-stroke samples. They examined gut bacteria carrying tnaA, which can convert dietary tryptophan into indole, and tested the role of the aryl hydrocarbon receptor (AHR) in intestinal dendritic cells.

Findings

In mice, indole-producing bacteria were more abundant in severe stroke, and experimental changes to the intestinal dendritic-cell AHR pathway altered immune-cell migration and brain injury. In the human cohort, greater abundance of bacterial tnaA was associated with poorer functional outcomes after stroke; the human data were observational.

Limits

The causal pathway was established in animal experiments, not in patients. The human association does not prove that microbial indole worsened outcomes or that changing the microbiome would improve recovery. Clinical applications require further study.

This sourced news summary and translation were prepared with AI assistance. Source links, the news date and research limitations are disclosed; this is not a claim of independent medical expert review. News production method.

Sources

Research news is not medical advice or a recommendation to use a substance. Read findings in the context of the study design, participants and limitations. Editorial standards.

← All news